Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-03-17 6:35 pm Purchase |
2025-03-10 | 13D | Senti Biosciences, Inc. SNTI |
BAYER HEALTHCARE LLC | 6,142,848 19.990% |
5,554,999 (+944.97%) |
Filing History |
| 2025-03-17 3:01 pm Unchanged |
2025-03-06 | 13D | Senti Biosciences, Inc. SNTI |
Celadon Partners SPV 24 | 9,777,000 37.600% |
0 (Unchanged) |
Filing History |
| 2025-03-13 4:31 pm Purchase |
2025-03-06 | 13D | Senti Biosciences, Inc. SNTI |
Celadon Partners SPV 24 | 9,777,000 37.600% |
9,777,000 (New Position) |
Filing History |
| 2025-03-10 7:00 pm Purchase |
2025-03-06 | 13D | Senti Biosciences, Inc. SNTI |
New Enterprise Associates 15 L.P. | 3,775,615 14.500% |
3,333,000 (+753.02%) |
Filing History |
| 2025-02-14 4:56 pm Purchase |
2024-12-31 | 13G | Senti Biosciences, Inc. SNTI |
Armistice Capital, LLC | 536,010 9.990% |
536,010 (New Position) |
Filing History |
| 2025-02-14 4:32 pm Purchase |
2024-12-31 | 13G | Senti Biosciences, Inc. SNTI |
Nantahala Capital Management, LLC | 509,283 9.990% |
509,283 (New Position) |
Filing History |
| 2025-02-14 4:31 pm Purchase |
2024-12-02 | 13G | Senti Biosciences, Inc. SNTI |
Nantahala Capital Partners Limited Partnership | 301,500 5.914% |
301,500 (New Position) |
Filing History |
| 2024-12-04 7:08 pm Purchase |
2024-12-02 | 13D | Senti Biosciences, Inc. SNTI |
New Enterprise Associates 15 L.P. | 442,615 9.600% |
442,615 (New Position) |
Filing History |
| 2023-02-14 12:38 pm Purchase |
2022-12-31 | 13G | Senti Biosciences, Inc. SNTI |
PRICE T ROWE ASSOCIATES INC | 355,402 8.100% |
355,402 (New Position) |
Filing History |
| 2023-02-14 11:52 am Unchanged |
2022-12-31 | 13G | Senti Biosciences, Inc. SNTI |
OZ MANAGEMENT LLC | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2023-02-13 5:14 pm Purchase |
2022-12-31 | 13G | Senti Biosciences, Inc. SNTI |
BAYER HEALTHCARE LLC | 587,849 13.400% |
587,849 (New Position) |
Filing History |
| 2023-02-10 4:09 pm Unchanged |
2022-12-31 | 13G | Senti Biosciences, Inc. SNTI |
Woodline Partners LP | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2023-02-09 4:06 pm Purchase |
2022-12-30 | 13G | Senti Biosciences, Inc. SNTI |
MORGAN STANLEY MS |
24,986 0.600% |
24,986 (New Position) |
Filing History |
| 2023-02-08 4:35 pm Purchase |
2022-06-08 | 13G | Senti Biosciences, Inc. SNTI |
Lonsdale Joe | 253,756 5.800% |
253,756 (New Position) |
Filing History |
| 2022-07-15 5:24 pm Purchase |
2022-06-08 | 13D | Senti Biosciences, Inc. SNTI |
New Enterprise Associates 15 L.P. | 442,615 10.100% |
442,615 (New Position) |
Filing History |
| 2022-04-05 11:21 am Sale |
2022-03-31 | 13G | Dynamics Special Purpose Corp. DYNS |
J P MORGAN CHASE & CO JPM |
551,978 2.300% |
-773,022 (-58.34%) |
Filing History |
| 2022-02-14 5:07 pm Sale |
2021-12-31 | 13G | Dynamics Special Purpose Corp. DYNS |
Redmile Group LLC | 0 0.000% |
-2,012,900 (Position Closed) |
Filing History |
| 2022-02-11 3:08 pm Purchase |
2021-12-31 | 13G | Dynamics Special Purpose Corp. DYNS |
OZ MANAGEMENT LLC | 1,540,293 6.490% |
2,981 (+0.19%) |
Filing History |
| 2022-02-11 07:26 am Purchase |
2021-12-31 | 13G | Dynamics Special Purpose Corp. DYNS |
Woodline Partners LP | 2,000,000 8.400% |
2,000,000 (New Position) |
Filing History |
| 2022-02-10 11:51 am Sale |
2021-12-31 | 13G | Dynamics Special Purpose Corp. DYNS |
MORGAN STANLEY MS |
2,890,650 12.200% |
-110,887 (-3.69%) |
Filing History |